Attention, counterfeit!

11 March 2020
A counterfeit of medicine Rigvir has been detected, which is being distributed in Russia, Ukraine, Kazakhstan and possibly other countries. Counterfeit medicines are easily identifiable visually.
In case of doubt, please contact the pharmaceutical manufacturer and the patent owner by sending information to e-mail: info@rigvir.com. Patients do not receive the prescribed therapy when using falsified medicines and has a high risk of poisoning with substances of unknown origin.

Contacts for Media Inquiries

Rigvir Group
Address: Atlasa street 7C, Riga, Latvia, LV-1026
Phone: +371 67 716 132
E-mail: pr@rigvir.com